Navigation Links
Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
Date:10/2/2007

Company enters $800 million market; Initial focus on oncology: most actively researched disease area Researchers to benefit from improved

reagent performance and enhanced productivity

NEWARK, Del., Oct. 2 /PRNewswire-FirstCall/ -- Strategic Diagnostics Inc. (Nasdaq: SDIX) -- today announced the launch of a new internet based catalog of antibody reagents in support of oncology-based research and discovery. These high-quality reagents have all been manufactured utilizing SDI's proprietary Genomic Antibody Technology(TM) and will carry the SEQer(TM) brand. The catalog is available at http://antibodies.sdix.com online.

The catalog has launched with an initial offering of over 200 affinity purified antibody reagents. The Company will supplement this with up to an additional 25 new reagents each week as it strives to become recognized as the fastest-growing site of high quality, leading edge reagents for cancer research.

"Standard antibody production technologies have not changed in more than 20 years," commented Matthew H. Knight, the Company's President and Chief Executive Officer. "The SEQer antibodies in this catalog represent a breakthrough in antibody production and deliver multiple high performance attributes that reduced time, effort and data variation in the laboratory. In addition, the process that produces these reagents is high throughput as evidenced by our initial commitment to add up to 25 new antibody reagents each week. As recognition of SEQer antibody performance grows, we intend to increase this rate."

Mr. Knight continued, "The launch of the SEQer catalog is a direct response to market research highlightin
'/>"/>

SOURCE Strategic Diagnostics Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Answerthink and LORENZ Life Sciences Group Announce Strategic Alliance for the SAP Life Science Industry
2. New Advances in Gastric Diagnostics: Smaller is Better
3. West Nile Virus Screening and Diagnostics Technology Emerges In Step with North American Outbreak
4. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
5. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
6. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
7. Immunomedics Reports Initial Clinical Results With Hpam4 For Pancreatic Cancer Therapy
8. Pharmacopeia Announces Positive Results from Initial DARA Clinical Trial
9. Phase I Results for ImClone Pipeline Anti-IGF-1R Monoclonal Antibody IMC-A12 Presented at ASCO
10. Vicals Vaxfectin Adjuvant With Needle-free Delivery Enhances DNA Vaccine Performance; Yields Antibody Responses Comparable to Electroporation Without Tolerability Issues
11. Positive Results Using Affitech-Identified Human Antibody That Blocks VEGF Binding to VEGF Receptor 2 in Preclinical Cancer Model Reported by Peregrine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... June 26, 2015 Research and ... "Vitamin D Market by Analog, Application, End-User & by Region ... their offering. This market is projected to reach ... D in different applications and rising opportunities in countries such ... , Italy , and Brazil ...
(Date:7/2/2015)... 2015 Numotion,s Board of Directors and ... Tamas Feitel has joined the Company as Chief ... highly successful 18 year career at GE serving in ... and productivity to result in significant industry leading growth ... Financial Officer for GE Healthcare Global Services, a $5B ...
(Date:7/2/2015)... 2015 The report "Silage Inoculants ... (Lactobacillus, Pediococcus & Enterococcus), Enzymes (Fibre-digesting & Starch-digesting), Crop-type ... Silage Inoculants & Enzymes Market is expected to reach ... from 2015 to 2020. Browse 75 ... 194 P ages and an in-depth ...
Breaking Medicine Technology:Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 2Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 3Numotion Names Tamas Feitel Chief Financial Officer 2Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 2Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 3Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 4
... LLC , an established CRO providing clinical research services ... biotechnology industry, announced today that President and CEO David ... Clinical Research in Emerging Countries conference July 28-29 ... ) The paradigm of traditional drug development ...
... (NASDAQ: ELGX ), developer and marketer of innovative ... three and six months ended June 30, 2011. ... are pleased with our progress during the quarter and remain ... goals for 2011.  In the second quarter, global revenue grew ...
Cached Medicine Technology:ClinStar to Present on Conducting Clinical Trials in Russia 2Endologix Reports 22% Second Quarter 2011 Revenue Growth 2Endologix Reports 22% Second Quarter 2011 Revenue Growth 3Endologix Reports 22% Second Quarter 2011 Revenue Growth 4Endologix Reports 22% Second Quarter 2011 Revenue Growth 5Endologix Reports 22% Second Quarter 2011 Revenue Growth 6Endologix Reports 22% Second Quarter 2011 Revenue Growth 7Endologix Reports 22% Second Quarter 2011 Revenue Growth 8Endologix Reports 22% Second Quarter 2011 Revenue Growth 9
(Date:7/2/2015)... York, NY (PRWEB) , ... July 02, 2015 ... ... City for Carpal Tunnel treatment and wrist pain treatment. Dr. Lev Kalika, founder ... NYDNRehab – and a leading international authority on the conservative treatment of back, ...
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... Hand sanitizers ... the current summer flu season, according to fresh water advocate and radio host Sharon ... the hands. Kleyne cautions that for maximum effectiveness, hand sanitizers must be applied correctly ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... the Gelatin Capsule manufacturers. The report is a valuable source of guidance and ... the global and Chinese market for the Gelatin Capsule industry including capacity, production, ...
(Date:7/2/2015)... , ... July 02, 2015 , ... As the world ... differently, but also how they interact with products in their everyday lives. Technology can ... and security systems to home entertainment and safety, as well as making kitchen tasks ...
(Date:7/2/2015)... ... July 02, 2015 , ... As part of the ... Thailand is expressing its gratitude to its patients from all around the world for ... are patients who are off on a dental tour (indeed, Thantakit is one of ...
Breaking Medicine News(10 mins):Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 2Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 3Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 4Health News:Summer flu season hand sanitizers are most effective when correctly applied reports fresh water advocate Sharon Kleyne 2Health News:Summer flu season hand sanitizers are most effective when correctly applied reports fresh water advocate Sharon Kleyne 3Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 2Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 3Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 4Health News:KillerApps.TV Teams with Mario Armstrong to Feature Smart Home Technology 2Health News:KillerApps.TV Teams with Mario Armstrong to Feature Smart Home Technology 3Health News:KillerApps.TV Teams with Mario Armstrong to Feature Smart Home Technology 4Health News:Thailand's Longest Established International Dental Center Celebrates Its 70th Anniversary with Promos Galore 2
... March 25 "Today was a monumental day on ... and provide long-term services and supports.We commend the Senate ... and supports in this year,s health care reform. Long-term ... role in America,s health care crisis. The needs are ...
... mice reports a more powerful immune response than from an ... much nicer it would be to get vaccinated by drinking ... , That might someday be the case, thanks to ... probiotics, which are healthy bacteria found in dairy products such ...
... 25 AmeriCares, a nonprofit international relief organization, is ... of lifesaving medicines and medical supplies to its partner, ... The medical aid will help people in the ... diarrhea and chronic diseases, in addition to pre-natal vitamins ...
... for best health plans in the countryEAGAN, Minn., ... of Minnesota announced today that it has earned ... health plans by the National Committee on Quality ... a private 501(c)(3) non-profit organization dedicated to driving ...
... March 25 Persons who purchased or paid for (in ... other entities that reimbursed for (in whole or in part) ... be eligible for relief as part of a $28 million ... GlaxoSmithKline ("GSK") manufactured between April 1, 2002 and March 4, ...
... Friday 20 March, US researcher Dr. Chris Beecher from the ... an N-methyl derivative of the amino acid glycine, at the ... a colleague of lead author Dr. Arun Sreekumar. The research ... 1,000 small molecules in tissues associated with prostate cancer. These ...
Cached Medicine News:Health News:Statement From Larry Minnix, President & CEO of the American Association of Homes and Services for the Aging, on the Senate Finance Committee Hearing 'The Role of Long-term Care in Health Reform' and the Reintroduction of the CLASS Act 2Health News:Statement From Larry Minnix, President & CEO of the American Association of Homes and Services for the Aging, on the Senate Finance Committee Hearing 'The Role of Long-term Care in Health Reform' and the Reintroduction of the CLASS Act 3Health News:Oral Yogurt 'Vaccine' Could Blunt Ouch Factor 2Health News:AmeriCares and International Medical Corps Partner to Bring Lifesaving Aid to Chad 2Health News:Blue Cross Earns Highest National NCQA Accreditation Status for Quality Service and Care 2Health News:Proposed Settlement Will Make Up to $28 Million Available to Individuals Who Purchased and Companies That Reimbursed for Paxil CR(R) 2Health News:A new approach to prostate cancer detection 2
... Opmi Vario/NC33 system microscope provides surgeons ... pathology. These microscopes are ideal for many ... compact. Ergonomically designed at every point of ... utilized in a surgical microscope allows intuitive ...
DUALSWITCH-SHUNTSYSTEM for L-P-Derivation...
26 cm - 10 1/4, 140 mm - 5 1/2, bayonet-shaped, flexible, 90 angle, 4 mm...
Toothed pituitary rongeur....
Medicine Products: